[1] [2] While these medications offer significant therapeutic benefits, fatigue is a side effect that some people experience, which can affect daily functioning and quality of life
Only if youre actually deficient
Dosing Considerations and MHRA Safety Guidance In clinical trials, retatrutide was administered via weekly subcutaneous injection at escalating doses of 112 mg, but the MHRA has issued no prescribing guidance and warns against its use outside approved trial settings
The most common are: People with pre-existing skin conditions, such as eczema, psoriasis, or rosacea, may also experience a change in their symptoms (for better or worse)
Dosage: 1 packet or 12 pumps of spray daily, or as directed by your healthcare professional